Psychopharmacology and Psychiatry Updates

247 Episodo

1. Treating Alcohol Use Disorder

   Publicado: 26/6/2022
2. Topiramate and Stimulant Replacement Therapy for Cocaine Use Disorder

   Publicado: 21/6/2022
3. Association Between Mood Disorders and COVID-19

   Publicado: 16/6/2022
4. Antidepressants and Naltrexone for Stimulant Use Disorder

   Publicado: 11/6/2022
5. CANMAT Task Force Recommendations for the Use of Ketamine

   Publicado: 6/6/2022
6. Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

   Publicado: 1/6/2022
7. Premenstrual Mood Syndromes

   Publicado: 27/5/2022
8. Stimulant Use Disorder: Diagnosis and Assessment

   Publicado: 22/5/2022
9. Zuranolone for Postpartum Depression

   Publicado: 17/5/2022
10. Long-Term Treatment of First Episode of Psychosis

    Publicado: 12/5/2022
11. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia

    Publicado: 7/5/2022
12. Health Issues in First Episode of Psychosis

    Publicado: 2/5/2022
13. Psychopharmacology for Treatment-Resistant Early Psychosis

    Publicado: 27/4/2022
14. Assessing and Treating Adult ADHD

    Publicado: 22/4/2022
15. Medications for Binge Eating Disorder

    Publicado: 17/4/2022
16. Antipsychotics for First Episodes of Psychosis

    Publicado: 12/4/2022
17. Effects on Suicidal Risk With Different Medications

    Publicado: 7/4/2022
18. Risks of Using Cannabinoids

    Publicado: 2/4/2022
19. Lithium: How to Manage Dosage

    Publicado: 28/3/2022
20. CBD as a Medication

    Publicado: 23/3/2022